Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia
Ishac Nazy, Stefan D. Jevtic, Jane C. Moore, Angela Huynh, James W. Smith, John G. Kelton, Donald M. Arnold
Topics & Concepts
ADAMTS13Platelet activationHeparinHeparin-induced thrombocytopeniaVon Willebrand factorPlatelet factor 4MedicineAntibodyPlateletImmunologyImmune systemInternal medicineHeparin-Induced Thrombocytopenia and ThrombosisPlatelet Disorders and TreatmentsSARS-CoV-2 and COVID-19 Research